ABSTRACT
Although rabies is endemic in Malawi, there have been no studies in which rabies virus was systematically investigated and characterized in multiple animal hosts in that country. In order to provide molecular epidemiological data on rabies virus in Malawi, 683 suspected rabies case reports from 2008 to 2021 were examined, and 46 (dog = 40, cow = 5, and cat = 1) viable rabies-positive brain samples archived at the Central Veterinary Laboratory (CVL), Lilongwe, Malawi, were analyzed genetically. The results showed an increase in the submission of brain samples from 2008 to 2010, with the highest number of submissions observed in 2020. Of the 683 case reports analyzed for the period under review, 38.1% (260/683) (CI: 34.44 - 41.84) were confirmed by direct fluorescent antibody test. Among the confirmed cases, 65.4% (170/260) (CI: 59.23 - 71.09) were canine rabies. Further, phylogenetic analysis revealed that sequences from different animal hosts clustered together within the Africa 1b lineage, suggesting that the strains circulating in livestock are similar to those in domestic dogs. This finding supports the hypothesis that canine rabies is spilling over to livestock and emphasizes the need for further studies to provide data for effective control of rabies in Malawi.
Subject(s)
Dog Diseases , Rabies virus , Rabies , Female , Cattle , Animals , Dogs , Rabies virus/genetics , Rabies/epidemiology , Rabies/veterinary , Phylogeny , Malawi/epidemiology , Molecular Epidemiology , Dog Diseases/epidemiology , LivestockABSTRACT
Brucellosis is an important zoonotic disease caused by members of the genus Brucella. Camel brucellosis has been reported in almost all camel-rearing countries in Africa and Asia. A cross-sectional study was conducted between February 2020 and February 2021 in Galkayo, Garowe, and Bosaso districts in the Puntland State of Somalia to investigate the seroprevalence and risk factors of brucellosis in camels. A competitive enzyme-linked immunosorbent assay (c-ELISA) was used to detect anti-Brucella antibodies, while a structured questionnaire was used to collect epidemiological data. A total of 441 camel sera were screened against Brucella antibodies. Thirty-one (7%; 95% CI: 4.8-9.8%) samples were positive, and thirteen (54.2%; 95% CI: 32.8-74.4%) out of the twenty-four farms sampled had at least one seropositive animal. Galkayo district had the highest number of Brucella-seropositive camels (10.3%), followed by Bosaso district (8.6%), while Garowe district had the lowest number of seropositive camels (1.4%). The binary logistic regression model revealed that camels in Galkayo district (p = 0.015; OR: 9.428; 95% CI: 1.539-57.755), camels from large herd sizes of >50 animals (p = 0.019; OR: 5.822; 95% CI: 1.336-25.371), and those in contact with small ruminants (p = 0.011; OR: 10.941; 95% CI: 1.728-69.285) were significantly associated with seropositive cases of camel brucellosis in the Puntland State of Somalia. The present study shows that Brucella infections in camels are prevalent in the three districts covered by the study. This poses a public health risk, because milk from these camels is used for human consumption. Studies focusing on the isolation of Brucella strains in camels and investigating brucellosis in ruminants and humans are recommended in the study area. Validation of serological tests-including c-ELISA-for Brucella antibody detection in camels is also needed.
